These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30606452)

  • 1. Genome Editing for Cardiovascular Diseases-A Brief Review for Cardiologists.
    Hagiwara N
    Am J Cardiol; 2019 Mar; 123(6):1002-1006. PubMed ID: 30606452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    Musunuru K
    J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic genome editing in cardiovascular diseases.
    Nishiga M; Qi LS; Wu JC
    Adv Drug Deliv Rev; 2021 Jan; 168():147-157. PubMed ID: 32092381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
    J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases.
    Kaur B; Perea-Gil I; Karakikes I
    Curr Cardiol Rep; 2018 Jun; 20(7):58. PubMed ID: 29860642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing for the Study of Cardiovascular Diseases.
    Chadwick AC; Musunuru K
    Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing in cardiovascular diseases.
    Strong A; Musunuru K
    Nat Rev Cardiol; 2017 Jan; 14(1):11-20. PubMed ID: 27609628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 technology and its application in haematological disorders.
    Zhang H; McCarty N
    Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
    Li Y; Song YH; Liu B; Yu XY
    Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
    Musunuru K
    JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 technology: applications and human disease modelling.
    Torres-Ruiz R; Rodriguez-Perales S
    Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C; Teoh SL; Das S
    Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.